The dexamethasone suppression test for diagnosing depression in stroke patients

Area of Science:

• Neurology
• Psychiatry
• Clinical Diagnostics

Background:

• Depression is a frequent and debilitating complication following a cerebrovascular accident (stroke).
• Clinical assessment of depression in stroke survivors can be complicated by the neurological effects of the stroke itself.
• A reliable laboratory test for diagnosing depression in this population is highly desirable.

Purpose of the Study:

• To review and evaluate the existing literature on the utility of the dexamethasone suppression test (DST) for diagnosing depression in patients who have experienced a stroke.
• To determine the diagnostic accuracy of the DST in this specific patient group.

Main Methods:

• A systematic review and evaluation of published studies investigating the dexamethasone suppression test (DST) in patients with post-stroke depression.
• Identification and analysis of nine relevant studies.
• Calculation of median sensitivity and specificity from the included studies.

Main Results:

• Significant heterogeneity was observed in the methodologies and reported results across the nine studies.
• The median specificity of the DST for diagnosing depression in stroke patients was 87%.
• The median sensitivity of the DST was found to be 47%.

Conclusions:

• The dexamethasone suppression test (DST) demonstrates promising specificity for identifying depression in stroke patients.
• Further research with rigorous methodology is needed to confirm these findings.
• The DST may serve as a valuable adjunct diagnostic tool for the subset of stroke patients with inconclusive clinical depression evaluations.